Pharmacists in Plymouth, Minnesota


93 Pharmacists found in Plymouth
female pharmacist

Sarah Phillips, PHARMD.


Pharmacist
6055 Nathan Ln N, Plymouth, MN 55442
763-463-4400    

male pharmacist

Dr. Sean M. Sauter, PHARMD


Pharmacist
16705 County Road 24, Plymouth, MN 55447
763-559-7591     763-577-2129

female pharmacist

Sheri Thompson


Pharmacist
4175 Vinewood Ln N, Plymouth, MN 55442
763-553-1757    



female pharmacist

Stephanie Michelle Walek


Pharmacist - Pharmacotherapy
2855 Campus Dr, Plymouth, MN 55441
763-577-7007    

male pharmacist

Steven Maershbecker, PHARM.D.


Pharmacist
6055 Nathan Ln N, Plymouth, MN 55442
763-463-4400    

female pharmacist

Subhashri Ram


Pharmacist
10200 6th Ave N, Plymouth, MN 55441
763-545-1916    

female pharmacist

Dr. Susan Anderson, PHARM D


Pharmacist
4005 Vinewood Lane N, Walgreens 02767, Plymouth, MN 55442
763-553-9731     763-553-9144

female pharmacist

Dr. Tamera Lynn Haase, PHARMD


Pharmacist
3255 Vicksburg Ln N, Plymouth, MN 55447
763-253-8917    

male pharmacist

Timothy Charles Krause, RPH


Pharmacist
4360 Kingsview Ln N, Plymouth, MN 55446
612-804-5445    

male pharmacist

Mr. Timothy Johnson, R.PH.


Pharmacist
2855 Campus Dr, Suite 180, Plymouth, MN 55441
763-577-7007    

female pharmacist

Va Vang, PHARMD


Pharmacist
3255 Vicksburg Ln N, Plymouth, MN 55447
763-253-8917    

male pharmacist

Wes Halverson


Pharmacist
6025 Shenandoah Ln N, Plymouth, MN 55446
763-252-1300     763-252-1306

male pharmacist

Younus Jamal Azam


Pharmacist
6055 Nathan Ln N # 200a, Plymouth, MN 55442
763-463-4400    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.